{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:26:49Z","timestamp":1761060409300},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10147-017-1184-0","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T07:17:51Z","timestamp":1504077471000},"page":"151-157","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Significance of multiple preoperative laboratory abnormalities as prognostic indicators in patients with urothelial carcinoma of the upper urinary tract following radical nephroureterectomy"],"prefix":"10.1007","volume":"23","author":[{"given":"Masatomo","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA et al (2011) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int 107:1059\u20131064","journal-title":"BJU Int"},{"key":"1184_CR2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115:1224\u20131233","journal-title":"Cancer"},{"key":"1184_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.eururo.2012.02.018","volume":"62","author":"M Rink","year":"2012","unstructured":"Rink M, Ehdaie B, Cha EK et al (2012) Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 62:677\u2013684","journal-title":"Eur Urol"},{"key":"1184_CR4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2011.07.009","volume":"60","author":"M Roscigno","year":"2011","unstructured":"Roscigno M, Brausi M, Heidenreich A et al (2011) Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 60:776\u2013783","journal-title":"Eur Urol"},{"key":"1184_CR5","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","volume":"116","author":"SF Matin","year":"2010","unstructured":"Matin SF, Margulis V, Kamat A et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116:3127\u20133134","journal-title":"Cancer"},{"key":"1184_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V et al (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62:100\u2013114","journal-title":"Eur Urol"},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0090-4295(00)00800-1","volume":"56","author":"MJ Scolieri","year":"2000","unstructured":"Scolieri MJ, Paik ML, Brown SL et al (2000) Limitations of computed tomography in the\u00a0preoperative\u00a0staging of\u00a0upper\u00a0tract\u00a0urothelial carcinoma. Urology 56:930\u2013934","journal-title":"Urology"},{"key":"1184_CR8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/iju.12587","volume":"21","author":"S Yoshida","year":"2014","unstructured":"Yoshida S, Koga F, Masuda H et al (2014) Role of diffusion-weighted\u00a0magnetic resonance\u00a0imaging as an imaging biomarker of\u00a0urothelial carcinoma. Int J Urol 21:1190\u20131200","journal-title":"Int J Urol"},{"key":"1184_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1590\/S1677-5538.IBJU.2014.06.06","volume":"40","author":"JH Ku","year":"2014","unstructured":"Ku JH, Kim M, Choi WS et al (2014) Preoperative serum\u00a0albumin\u00a0as a prognostic factor in patients with\u00a0upper\u00a0urinary tract\u00a0urothelial carcinoma. Int Braz J Urol 40:753\u2013762","journal-title":"Int Braz J Urol"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2013.09.010","volume":"191","author":"M Rink","year":"2014","unstructured":"Rink M, Sharifi N, Fritsche HM et al (2014) Impact of preoperative\u00a0anemia\u00a0on oncologic outcomes of\u00a0upper\u00a0tract\u00a0urothelial carcinoma treated with radical nephroureterectomy. J Urol 191:316\u2013322","journal-title":"J Urol"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1464-410X.2007.06934.x","volume":"100","author":"K Saito","year":"2007","unstructured":"Saito K, Kawakami S, Ohtsuka Y et al (2007) The\u00a0impact\u00a0of\u00a0preoperative\u00a0serum\u00a0C-reactive protein\u00a0on the\u00a0prognosis\u00a0of\u00a0patients\u00a0with\u00a0upperurinary tract\u00a0urothelial carcinoma\u00a0treated\u00a0surgically. BJU Int 100:269\u2013273","journal-title":"BJU Int"},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"417.e9","DOI":"10.1016\/j.urolonc.2016.04.001","volume":"34","author":"M Nishikawa","year":"2016","unstructured":"Nishikawa M, Miyake H, Fujisawa M (2016) De Ritis (aspartate transaminase\/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with\u00a0upper\u00a0urinary tract urothelial carcinoma following nephroureterectomy. Urol Oncol 34:417.e9\u2013417.e15","journal-title":"Urol Oncol"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11255-015-1033-x","volume":"47","author":"S Morizane","year":"2015","unstructured":"Morizane S, Yumioka T, Yamaguchi N et al (2015) Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with\u00a0upper\u00a0urinary tract\u00a0urothelial carcinoma undergoing radical nephroureterectomy. Int Urol Nephrol 47:1335\u20131341","journal-title":"Int Urol Nephrol"},{"issue":"341\u2013345","key":"1184_CR14","first-page":"e3","volume":"14","author":"XK Zhang","year":"2016","unstructured":"Zhang XK, Zhang ZL, Lu X et al (2016) Prognostic significance of preoperative serum lactate dehydrogenase in\u00a0upper\u00a0urinary tracturothelial carcinoma. Clin Genitourin Cancer 14(341\u2013345):e3","journal-title":"Clin Genitourin Cancer"},{"key":"1184_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bju.12441","volume":"114","author":"O Dalpiaz","year":"2014","unstructured":"Dalpiaz O, Ehrlich GC, Mannweiler S et al (2014) Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with\u00a0upper\u00a0tract\u00a0urothelial carcinoma. BJU Int 114:334\u2013339","journal-title":"BJU Int"},{"key":"1184_CR16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1442-2042.2012.03228.x","volume":"20","author":"K Fujita","year":"2013","unstructured":"Fujita K, Tanigawa G, Imamura R et al (2013) Preoperative serum sodium\u00a0is\u00a0associated with\u00a0cancer-specific survival\u00a0in\u00a0patients\u00a0with\u00a0upper urinary tract urothelial carcinoma treated\u00a0bynephroureterectomy. Int J Urol 20:594\u2013601","journal-title":"Int J Urol"},{"key":"1184_CR17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.juro.2013.10.073","volume":"191","author":"M Pichler","year":"2014","unstructured":"Pichler M, Dalpiaz O, Ehrlich GC et al (2014) Validation of the preoperative plasma\u00a0fibrinogen\u00a0level as a prognostic factor in a European cohort of patients with localized\u00a0upper\u00a0tract\u00a0urothelial carcinoma. J Urol 191:920\u2013925","journal-title":"J Urol"},{"key":"1184_CR18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1089\/end.2007.0154","volume":"22","author":"T Terakawa","year":"2008","unstructured":"Terakawa T, Miyake H, Hara I et al (2008) Retroperitoneoscopic nephroureterectomy for upper urinary tract cancer: a comparative study with conventional open retroperitoneal nephroureterectomy. J Endourol 22:1693\u20131699","journal-title":"J Endourol"},{"key":"1184_CR19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","volume":"68","author":"M Roupr\u00eat","year":"2015","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E et al (2015) European association of urology guidelines on\u00a0upper\u00a0urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68:868\u2013879","journal-title":"Eur Urol"},{"key":"1184_CR20","unstructured":"NCCN guidelines. Clinical guidelines in oncology. Bladder cancer, version 2.2012. National Comprehensive Cancer NetworkWeb site. http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp . Accessed 12 Jan 2016"},{"key":"1184_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jnci\/86.2.120","volume":"86","author":"SM Scholl","year":"1994","unstructured":"Scholl SM, Pallud C, Beuvon F et al (1994) Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86:120\u2013126","journal-title":"J Natl Cancer Inst"},{"key":"1184_CR22","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D","volume":"86","author":"BC Sheu","year":"1999","unstructured":"Sheu BC, Hsu SM, Ho HN et al (1999) Reversed CD4\/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 86:1537\u20131543","journal-title":"Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-017-1184-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T15:25:48Z","timestamp":1719415548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-017-1184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s10147-017-1184-0","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]}}}